Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EBA and Safety of Pyrifazimine in Pulmonary Tuberculosis
NCT04670120Phase 2Unknown
- Sponsor
- Beijing Chest Hospital
- Start
- Mar 2021
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pirfazimine in pulmonary tuberculosis (TB), sponsored by Beijing Chest Hospital. Status: unknown.
02
Drugs
pirfazimine
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT04670120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04670120.